Nova Patents
AT443062T

N-heteroarylnicotinamide derivatives

Abstract

This record has no abstract on file.

Term

Term ended

Expired 19 November 2022, 3.8 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

41 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
2001355561JapanA
2002065193JapanA
0212078JapanW

Members41

Family members, oldest first
DocumentOfficeKind
CA2467575A1CanadaA1
WO03044013A1World Intellectual Property Organization (WIPO)A1
AU2002366027A1AustraliaA1
TW200301078ATaiwan Province of ChinaA
JP3456702B1JapanB1
JP2003335778AJapanA
KR20040066833ARepublic of KoreaA
MXPA04004806AMexicoA
EP1460071A1European Patent Office (EPO)A1
BR0214448ABrazilA
US2005004368A1United States of AmericaA1
JPWO2003044013A1JapanA1
EP1460071A4European Patent Office (EPO)A4
RU2004118505ARussian FederationA
HU0500026A2HungaryA2
HUP0500026A2HungaryA2
PL370628A1PolandA1
ZA200404009BSouth AfricaB
CN1692111AChinaA
IL162035A0IsraelA0
NZ533545ANew ZealandA
US7015236B2United States of AmericaB2
HK1083494AHong Kong, ChinaA
HK1083494A1Hong Kong, ChinaA1
TWI264287BTaiwan Province of ChinaB
RU2294329C2Russian FederationC2
AU2002366027B2AustraliaB2
HU0500026A3HungaryA3
HUP0500026A3HungaryA3
CN100425609CChinaC
EP1460071B1European Patent Office (EPO)B1
AT443062TThis recordAustriaT
ATE443062T1AustriaT1
KR100923835B1Republic of KoreaB1
DE60233751D1GermanyD1
IL162035AIsraelA
ES2331356T3SpainT3
CA2467575CCanadaC
PL207756B1PolandB1
HU228641B1HungaryB1
BRPI0214448B1BrazilB1